Unraveling the physiological function and mechanism of OGC‐mediated mitochondrial uncoupling has the potential to provide insight into its involvement in cancer metabolism and aid in the development of targeted drugs for other metabolic diseases. This evidence concerns the gene SLC25A11 and cancer.